AEC firms must adapt to the new law s impact on tariffs, permitting and incentives by embedding strategic communication ...

Complete Response Letters recently issued by the FDA signal heightened scrutiny of trial design and reinforce the agency’s shifting regulatory expectations for sponsors and CROs.

True intelligence isn't just about what you know; it's profoundly reflected in how you communicate. While anyone can fall ...